Cell cycle-dependent expression of p42.3 promotes mitotic progression in malignant transformed cells

Molecular Carcinogenesis

Volumn 53, Issue 5, 2014, Pages 337-348

  Mao, Linlin ^a   Sun, Wei ^a   Li, Wenmei ^a   Cui, Jiantao ^a   Zhang, Jingyu ^a   Xing, Rui ^a   Lu, Youyong ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Cell cycle; Cell transformation; Early G1; Mitotic progression; P42.3

Indexed keywords

CYCLIN B1; MESSENGER RNA; PROTEIN P42;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL STRAIN 3T3; CELL TRANSFORMATION; CHROMOSOME SEGREGATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE; UPREGULATION;

CELL CYCLE; CELL TRANSFORMATION; EARLY G1; MITOTIC PROGRESSION; P42.3;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, FLUORESCENCE; MITOSIS; NIH 3T3 CELLS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 84898058572     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.21982     Document Type: Article

References (27)

1. Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: A changing paradigm. Nat Rev Cancer 2009; 9:153-166.
2. Zhou BB, Elledge SJ. The DNA damage response: Putting checkpoints in perspective. Nature 2000; 408:433-439.
3. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature 2004; 432:316-323.
4. Perez de Castro I, de Carcer G, Malumbres M. A census of mitotic cancer genes: New insights into tumor cell biology and cancer therapy. Carcinogenesis 2007; 28:899-912.
5. Lapenna S, Giordano A. Cell cycle kinases as therapeutic targets for cancer. Nat Rev Drug Discov 2009; 8:547-566.
6. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144:646-674.
7. Maiato H. Mitosis: Wisdom, knowledge, and information. Cell Mol Life Sci 2010; 67:2141-2143.
8. Musacchio A, Salmon ED. The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Bio 2007; 8:379-393.
9. Ciliberto A, Shah JV. A quantitative systems view of the spindle assembly checkpoint. Embo J 2009; 28:2162-2173.
10. Scolnick DM, Halazonetis TD. Chfr defines a mitotic stress checkpoint that delays entry into metaphase. Nature 2000; 406:430-435.
11. Steigemann P, Wurzenberger C, Schmitz M, et al. Aurora B-mediated abscission checkpoint protects against tetraploidization. Cell 2009; 136:473-484.
12. Xu X, Li W, Fan X, et al. Identification and characterization of a novel p42.3 gene as tumor-specific and mitosis phase-dependent expression in gastric cancer. Oncogene 2007; 26:7371-7379.
13. Kang T, Wei Y, Honaker Y, et al. GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. Cancer Cell 2008; 13:36-47.
14. Wang Y, Zhan Q. Cell cycle-dependent expression of centrosomal ninein-like protein in human cells is regulated by the anaphase-promoting complex. J Biol Chem 2007; 282:17712-17719.
15. Tang CJ, Fu RH, Wu KS, Hsu WB, Tang TK. CPAP is a cell-cycle regulated protein that controls centriole length. Nat Cell Biol 2009; 11:825-831.
16. Jin HS, Lee TH. Cell cycle-dependent expression of cIAP2 at G2/M phase contributes to survival during mitotic cell cycle arrest. Biochem J 2006; 399:335-342.
17. Carleton M, Cleary MA, Linsley PS. MicroRNAs and cell cycle regulation. Cell Cycle 2007; 6:2127-2132.
18. Cui Y, Su WY, Xing J, et al. MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer. PLoS ONE 2011; 6:e25872.
19. Szyf M, Kaplan F, Mann V, et al. Cell cycle-dependent regulation of eukaryotic DNA methylase level. J Biol Chem 1985; 260:8653-8656.
20. Hamid T, Malik MT, Kakar SS. Ectopic expression of PTTGI/securin promotes tumorigenesis in human embryonic kidney cells. Mol Cancer 2005; 4:1-13.
21. Shao S, Liu R, Wang Y, et al. Centrosomal Nlp is an oncogenic protein that is gene-amplified in human tumors and causes spontaneous tumorigenesis in transgenic mice. J Clin Invest 2010; 120:498-507.
22. Vecchione A, Baldassarre G, Ishii H, et al. Fez1/Lzts1 absence impairs Cdk1/Cdc25C interaction during mitosis and predisposes mice to cancer development. Cancer Cell 2007; 11:275-289.
23. Jung Y, Lee S, Choi HS, et al. Clinical validation of colorectal cancer biomarkers identified from bioinformatics analysis of public expression data. Clin Cancer Res 2011; 17:700-709.
24. Gavet O, Pines J. Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. Dev Cell 2010; 18:533-543.
25. Agarwal R, Gonzalez-Angulo AM, Myhre S, et al. Integrative analysis of cyclin protein levels identifies Cyclin B1 as a classifier and predictor of outcomes in breast cancer. Clin Cancer Res 2009; 15:3654-3662.
26. Begnami MD, Fregnani JH, Nonogaki S, Soares FA. Evaluation of cell cycle protein expression in gastric cancer: Cyclin B1 expression and its prognostic implication. Hum Pathol 2010; 41:1120-1127.
27. Hutchins JR, Toyoda Y, Hegemann B, et al. Systematic analysis of human protein complexes identifies chromosome segregation proteins. Science 2010; 328:593-599.